Do e-cigarettes increase cancer risk?

New evidence links vaping to cancer risk

An Australian review of the evidence finds that vaping is likely to cause cancer, with researchers concluding that inhalation from e-cigarettes alters cells and tissues in the oral cavity and lungs. The review’s language is direct: “There is no doubt” that vaping affects tissue changes in these areas, which matters because such alterations can be an early step in cancer development.

The findings align with a broader public-health debate about how quickly health effects emerge after vaping—and whether the current evidence base is strong enough to justify precautionary policies. While the review focuses on cancer likelihood and biological plausibility rather than reporting individual long-term cancer outcomes in the snippet provided, the emphasis on tissue alteration strengthens concern that the risk is not just theoretical.

Why it matters for policy and prevention

• Target organs are clear: the oral cavity and lungs are directly exposed, which is where cancer risk is most biologically plausible.
• Mechanism is emphasized: tissue and cellular changes provide a rationale for why cancer risk could rise over time.
• It supports harm-reduction scrutiny: public-health agencies typically weigh relative risks against smoking, but this kind of conclusion increases pressure for stronger anti-vaping measures—especially for youth and non-smokers.

For consumers, the most practical takeaway is that vaping should not be treated as harmless. For regulators, evidence reviews that point to cancer likelihood often become a basis for enforcement actions such as advertising restrictions, product standards, and limitations on youth access.

The review described in the report is from Australian researchers; details beyond the tissue-alteration conclusions were not provided in the snippet.